MAUDE Adverse Event Report: INSTITUT STRAUMANN AG TE Ø 4.1MM RN, SLACTIVE® 14MM, TIZR, NTP; ENDOSSEOUS DENTAL IMPLANT

Catalog Number	033.574S
Medical Device Problem Code	Failure to Osseointegrate (1863)
Health Effect - Clinical Code	Fibrosis (3167)
Date of Event	12/15/2023
Type of Reportable Event	Serious Injury
Event or Problem Description
The clinician reports the implant was inserted (b)(6) 2023 in ada 22.Details of surgery: ridge augmentation.On (b)(6) 2023, non-osseointegration was verified.Patient presented with bone type iii, fair oral hygiene and inadequate bone quality/quantity.The device was forwarded to the manufacturer.At the event the patient experienced: mobility.No further patient complications were reported.

• Brand Name: TE Ø 4.1MM RN, SLACTIVE® 14MM, TIZR, NTP
• Common Device Name: ENDOSSEOUS DENTAL IMPLANT
• Manufacturer (Section D): INSTITUT STRAUMANN AG; peter merian-weg 12; basel 04002 ; SZ 04002
• MDR Report Key: 18511429
• Report Number: 0001222315-2024-001221
• Device Sequence Number: 17060096
• Product Code: DZE
• UDI-Device Identifier: 07630031716064
• UDI-Public: 07630031716064
• Combination Product (Y/N): N
• Initial Reporter State: SC
• Initial Reporter Country: US
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2023
• Device Explanted Year: 2023
• Serviced by Third Party (Y/N): N
• Reporter Type: Importer
• Initial Reporter Occupation: Dentist
• Type of Report: Initial
• Report Date (Section B): 01/15/2024
• Report Date (Section F): 12/22/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Expiration Date: 07/30/2025
• Device Catalogue Number: 033.574S
• Device Lot Number: CHN38
• Was Device Available for Evaluation?: Device Returned to Manufacturer
• Date Returned to Manufacturer: 12/22/2023
• Is the Reporter a Health Professional?: Yes
• Was the Report Sent to FDA?: No
• Distributor Facility Aware Date: 01/15/2024
• Device Age: 41 MO
• Event Location: Other
• Date Report to Manufacturer: 12/22/2023
• Initial Date Received by Manufacturer: Not provided
• Initial Report FDA Received Date: 01/15/2024
• Was Device Evaluated by Manufacturer? (Y/N): Yes
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 61 YR
• Patient Sex: Female